Michael P. Manns

122.7k citations

1.3k papers · 76.8k indexed · 20 hit papers · h-index 128

Impact in

Hepatology top 0.01%
- Hepatitis C virus research
- Liver Diseases and Immunity
- Liver Disease and Transplantation
- Hepatitis Viruses Studies and Epidemiology
Epidemiology top 0.01%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies

Papers in

Hepatology 813
- Hepatitis C virus research 436
- Liver Diseases and Immunity 207
- Liver Disease and Transplantation 176
- Hepatitis Viruses Studies and Epidemiology 87
Epidemiology 668
- Liver Disease Diagnosis and Treatment 488
- Hepatitis B Virus Studies 350

Co-authors: Heiner Wedemeyer Christian Trautwein John G. McHutchison Christian P. Strassburg Janice K. Albrecht Zachary Goodman Tim F. Greten Firouzeh Korangy
Journals: Journal of Hepatology (152 papers)Hepatology (98 papers)Gastroenterology (68 papers)Liver International (44 papers)Journal of Viral Hepatitis (34 papers)
Partner nations: Germany United States France

In The Last Decade

Michael P. Manns

1.3k papers receiving 74.8k citations

Hit Papers

15 papers align trajectories log scale

Primary sclerosing cholangitis 2025 · 13 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2025 Nature Reviews Disease Primers
2022 Nature Reviews Gastroenterology & Hepatology
2019 Hepatology
2018 Nature Reviews Disease Primers
2017 Nature Reviews Disease Primers
2017 Journal of Hepatology
2012 JAMA
2011 New England Journal of Medicine
2010 Hepatology
2010 New England Journal of Medicine
2009 Hepatology
2008 Gastroenterology
2006 Gut
2005 Cancer Research
2003 Hepatology
2002 Gastroenterology
2002 Gastroenterology
2001 The Lancet
2001 New England Journal of Medicine
1994 Hepatology

Peers

Countries citing papers authored by Michael P. Manns

Since Specialization

Citations

This map shows the geographic impact of Michael P. Manns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael P. Manns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael P. Manns more than expected).

Fields of papers citing papers by Michael P. Manns

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael P. Manns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael P. Manns. The network helps show where Michael P. Manns may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael P. Manns, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael P. Manns Line = papers co-authored together Michael P. Manns links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	From model to man: Understanding Tregs' dual role in MASLD JHEP Reports ·Janine Dywicki, Laura Elisa Buitrago‐Molina, Anna Baumann, Ana Clara Marques Davalos‐Misslitz, manscan, Ru‐Feng Liu, 村井達哉, Jérôme Schlué, Matthias Blüher, Heike Bantel, Christine S. Falk, Christian Koenecke, Yanqi Cheng, Benjamin Heidrich, Michael P. Manns, Fatih Noyan, Heiner Wedemeyer, Richard Taubert, Elmar Jaeckel, Matthias Hardtke‐Wolenski	2025	1
2	Increase of α-dicarbonyls in liver and receptor for advanced glycation end products on immune cells are linked to nonalcoholic fatty liver disease and liver cancer OncoImmunology ·G. Bruno, Lavinia Neubert, Mohammad Fathor Iman, Kai Timrott, Huizhen Suo, A. Jördens, René Huber, Yohanna Magdalena Lidya Gultom, Zdena Cervenka, Andriy S. Yatsenko, Halyna R. Shcherbata, Heiner Wedemeyer, Ralf Lichtinghagen, Halina Falfushynska, Volodymyr I. Lushchak, Michael P. Manns, Heike Bantel, Halyna Semchyshyn, Tetyana Yevsa	2021	14
3	Fully automated detection of primary sclerosing cholangitis (PSC)-compatible bile duct changes based on 3D magnetic resonance cholangiopancreatography using machine learning European Radiology ·Kristina I. Ringe, 五郎薮田, Frank Wacker, Henrike Lenzen, Michael P. Manns, Christian Hundt, Bertil Schmidt, J. Bonamy	2020	11
4	Predniso(lo)ne Dosage and Chance of Remission in Patients With Autoimmune Hepatitis Clinical Gastroenterology and Hepatology ·Simon Pape, Tom J.G. Gevers, Tae Lim Sin, Gerhard Ernst, Jan Maarten Vrolijk, Bart van Hoek, Gerd Bouma, Carin M.J. van Nieuwkerk, Johannes Hartl, Christoph Schramm, Ansgar W. Lohse, Richard Taubert, Elmar Jaeckel, Michael P. Manns, Mária Papp, Felix Stickel, Michael A. Heneghan, Joost P.H. Drenth	2019	45
5	Chronic hepatitis delta virus infection leads to functional impairment and severe loss of MAIT cells Journal of Hepatology ·Joana Dias, Julia Hengst, Tiphaine Parrot, Edwin Leeansyah, Sebastian Lunemann, David F. G. Malone, Svenja Hardtke, Otto Strauß, Christine L. Zimmer, Lena Berglin, Clarice Mariano Fernandes ELPO, Sandra Ciesek, Nicole Marquardt, Thomas von Hahn, Michael P. Manns, Markus Cornberg, Hans‐Gustaf Ljunggren, Heiner Wedemeyer, Johan K. Sandberg, Niklas K. Björkström	2019	64
6	Viral eradication is required for sustained improvement of patient‐reported outcomes in patients with hepatitis C Liver International ·Zobair M. Younossi, Maria Stepanova, K. Rajender Reddy, Michael P. Manns, Marc Bourlière, Stuart C. Gordon, Eugene R. Schiff, Tram T. Tran, Issah Younossi, Andrei Racila	2018	24
7	Chronic hepatitis C virus infection irreversibly impacts human natural killer cell repertoire diversity Nature Communications ·Benedikt Strunz, Julia Hengst, Katja Deterding, Michael P. Manns, Markus Cornberg, Hans‐Gustaf Ljunggren, Heiner Wedemeyer, Niklas K. Björkström	2018	64
8	Perioperative, Spatiotemporally Coordinated Activation of T and NK Cells Prevents Recurrence of Pancreatic Cancer Cancer Research ·Jennifer D. Brooks, Bettina Fleischmann-Mundt, Norman Woller, 唯信岩崎, Silvia Ribback, Tagipour Javan Abbas Ali, İhsan Ekin Demir, J. VOIRON, Güralp O. Ceyhan, Michael P. Manns, Thomas Wirth, Stefan Kubicka, Günter Bernhardt, Mark J. Smyth, Diego F. Calvisi, Engin Gürlevik, Florian Kühnel	2017	55
9	CD40 Signaling Drives Potent Cellular Immune Responses in Heterologous Cancer Vaccinations Cancer Research ·Liu Baixing, Dmitrij Ostroumov, Yosuke TAKIGUCHI, Sarah Knocke, Norman Woller, Engin Gürlevik, Christine S. Falk, Michael P. Manns, Florian Kühnel, Thomas Wirth	2017	32
10	Lipid-lowering therapy with PCSK9-inhibitors in the management of cardiovascular high-risk patients: Effectiveness, therapy adherence and safety in a real world cohort Cardiology Journal ·Michael Saborowski, A Piro, Michael P. Manns, Holger Leitolf, Steffen Zender	2017	35
11	Improvement of liver function parameters in advanced HCV ‐associated liver cirrhosis by IFN ‐free antiviral therapies Alimentary Pharmacology & Therapeutics ·Katja Deterding, Christoph Höner zu Siederdissen, Kerstin Port, Philipp Solbach, Sushma Sharma, J. Kirschner, Carola Mix, 佳奈子平野, J. Chamcheu, Heiko Mix, Michael P. Manns, Markus Cornberg, Heiner Wedemeyer	2015	87
12	C-Myc plays a crucial role in chronic liver injury Journal of Viral Hepatitis ·李静睿, М. В. Патика, Bruno Guigas, O. A. Alduhov, Jessica Endig, Ulrika Bärdén, Silke Marhenke, Michael P. Manns, Arthur Vogel	2015	1
13	Efficacy and Safety of Faldaprevir, Deleobuvir, and Ribavirin in Treatment-Naive Patients with Chronic Hepatitis C Virus Infection and Advanced Liver Fibrosis or Cirrhosis Antimicrobial Agents and Chemotherapy ·Stefan Zeuzem, Vincent Soriano, Tarik Asselah, Edward Gane, Jean–Pierre Bronowicki, Peter Angus, Ansgar W. Lohse, Felix Stickel, Beat Müllhaupt, Stuart K. Roberts, Marcus Schuchmann, Michael P. Manns, Marc Bourlière, Marı́a Buti, Jerry O. Stern, Sophie Fischer, Florian Voß, John P. Sabo, Wulf O. Böcher, Federico Mensa	2014	8
14	BRaf and MEK Inhibitors Differentially Regulate Cell Fate and Microenvironment in Human Hepatocellular Carcinoma Clinical Cancer Research ·Christian Breunig, Rikuo Omae, Ludmila Umansky, Kristin Wahl, Katrin Hoffmann, Frank Lehner, Michael P. Manns, Heike Bantel, Christine S. Falk	2014	17
15	Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells Blood ·Bastian Hoechst, Jaba Gamrekelashvili, Michael P. Manns, Tim F. Greten, Firouzeh Korangy	2011	198
16	Boceprevir, an NS3 serine protease inhibitor of hepatitis C virus, for the treatment of HCV infection. PubMed ·Ingmar Mederacke, Heiner Wedemeyer, Michael P. Manns	2009	36
17	Genetically Induced Pancreatic Adenocarcinoma Is Highly Immunogenic and Causes Spontaneous Tumor-Specific Immune Responses Cancer Research ·Annette I. Garbe, E.Yu. Bulatov, Jaba Gamrekelashvili, Reinhard von Wasielewski, Florian R. Greten, Astrid M. Westendorf, Jan Buer, Roland M. Schmid, Michael P. Manns, Firouzeh Korangy, Tim F. Greten	2006	34
18	Testing the importance of p27 degradation by the SCF ^skp2 pathway in murine models of lung and colon cancer Proceedings of the National Academy of Sciences ·Liang WU, Carrie M. Garrett-Engele, Uta Kossatz-Boehlert, Xueyan Chen, Eduardo Firpo, Viktor Grünwald, Kenji Kamino, Ludwig Wilkens, Ulrich Lehmann, Jan Buer, Robert Geffers, Stefan Kubicka, Michael P. Manns, Peggy L. Porter, James M. Roberts, Nisar P. Malek	2006	60
19	Primary human mast cells express specific isoforms of SNARE proteins Journal of Allergy and Clinical Immunology ·Leif Erik Sander, Vikram Venkataraman, J. Klempnauer, Michael P. Manns, S.C. Bischoff, Axel Lorentz	2005	2
20	Fortschritte in der Ultraschalldiagnostik bei Lebererkrankungen DMW - Deutsche Medizinische Wochenschrift ·Juliana Leal Fagundes Neves, Glanelz Lh, 蔡振寨, Michael P. Manns	2001	1

About Michael P. Manns

Michael P. Manns is a scholar working on Hepatology, Epidemiology, Transplantation, Immunology and Pharmacology, having authored 1.3k papers that have together received 76.8k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (488 papers), Hepatitis C virus research (436 papers), Hepatitis B Virus Studies (350 papers), Liver Diseases and Immunity (207 papers), Liver Disease and Transplantation (176 papers), Hepatitis Viruses Studies and Epidemiology (87 papers), Systemic Lupus Erythematosus Research (66 papers) and Organ Transplantation Techniques and Outcomes (65 papers). The work is most often cited by research in Hepatology (46.8k citations), Epidemiology (41.9k citations), Transplantation (1.4k citations), Immunology (10.2k citations) and Pharmacology (3.3k citations). Michael P. Manns has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Heiner Wedemeyer, Christian Trautwein, John G. McHutchison, Christian P. Strassburg, Janice K. Albrecht, Zachary Goodman, Tim F. Greten, Firouzeh Korangy, Markus Cornberg and Hans L. Tillmann. Their work appears in journals such as Journal of Hepatology, Hepatology, Gastroenterology, Liver International and Journal of Viral Hepatitis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact